JP5864589B2 - 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類 - Google Patents

細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類 Download PDF

Info

Publication number
JP5864589B2
JP5864589B2 JP2013532015A JP2013532015A JP5864589B2 JP 5864589 B2 JP5864589 B2 JP 5864589B2 JP 2013532015 A JP2013532015 A JP 2013532015A JP 2013532015 A JP2013532015 A JP 2013532015A JP 5864589 B2 JP5864589 B2 JP 5864589B2
Authority
JP
Japan
Prior art keywords
ethylcarbamoylamino
benzothiazol
piperidine
pyrimidin
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013532015A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013542204A5 (enExample
JP2013542204A (ja
Inventor
ティー パルマー,ジェームス
ティー パルマー,ジェームス
ジェームス ルニス,クリストファー
ジェームス ルニス,クリストファー
エー オファーマン,ダニエル
エー オファーマン,ダニエル
クレール アックスフォード,ローライン
クレール アックスフォード,ローライン
ブレア,マイケル
ロバート ミッチェル,デール
ロバート ミッチェル,デール
ジョン パルマー,ニコラス
ジョン パルマー,ニコラス
ステル,クリストファー
アセラル,ジョン
ワトソン,デイビッド
ジョン ハイドン,デイビッド
ジョン ハイドン,デイビッド
ジョージ ツザプルウスキ,ロイド
ジョージ ツザプルウスキ,ロイド
デイビーズ,デイビッド
コリンズ,イアン
マルコム ティンデル,エドワード
マルコム ティンデル,エドワード
アンドロー,ローラ
ロバート ウイリアム ピット,ゲーリー
ロバート ウイリアム ピット,ゲーリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Europe Ltd
Original Assignee
Biota Europe Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Europe Ltd filed Critical Biota Europe Ltd
Publication of JP2013542204A publication Critical patent/JP2013542204A/ja
Publication of JP2013542204A5 publication Critical patent/JP2013542204A5/ja
Application granted granted Critical
Publication of JP5864589B2 publication Critical patent/JP5864589B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/28—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
    • A01N47/36—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the group >N—CO—N< directly attached to at least one heterocyclic ring; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2013532015A 2010-10-08 2011-10-07 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類 Expired - Fee Related JP5864589B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39116310P 2010-10-08 2010-10-08
US61/391,163 2010-10-08
PCT/AU2011/001284 WO2012045124A1 (en) 2010-10-08 2011-10-07 Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls

Publications (3)

Publication Number Publication Date
JP2013542204A JP2013542204A (ja) 2013-11-21
JP2013542204A5 JP2013542204A5 (enExample) 2014-11-27
JP5864589B2 true JP5864589B2 (ja) 2016-02-17

Family

ID=45925612

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013532015A Expired - Fee Related JP5864589B2 (ja) 2010-10-08 2011-10-07 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類

Country Status (6)

Country Link
US (1) US9181234B2 (enExample)
EP (1) EP2625178A4 (enExample)
JP (1) JP5864589B2 (enExample)
CN (1) CN103249732B (enExample)
AU (1) AU2011313820A1 (enExample)
WO (1) WO2012045124A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015514063A (ja) * 2012-03-22 2015-05-18 ビオタ ヨーロッパ リミテッドBiota Europe Ltd 抗菌化合物

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6085829B2 (ja) 2011-01-14 2017-03-01 スペロ トリネム, インコーポレイテッド ピリミジンジャイレースおよびトポイソメラーゼiv阻害剤
MX341342B (es) 2011-01-14 2016-08-17 Vertex Pharma Formas solidas del inhibidor de girasa (r)-1-etil-3-[6-fluoro-5-[2 -(1-hidroxi-1-metil-etil) pirimidin-5-il]-7-(tetrahidrofuran-2-il) -1h-benzimidazol-2-il]urea.
US8481552B2 (en) 2011-01-14 2013-07-09 Vertex Pharmaceuticals Incorporated Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-YL]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-YL]urea
KR101882172B1 (ko) 2011-01-14 2018-07-26 스페로 트리넴, 인코포레이티드 자이라제 및 토포이소머라제 ⅳ 억제제의 제조방법
ES2576298T3 (es) 2011-06-20 2016-07-06 Vertex Pharmaceuticals Incorporated Ésteres de fosfato de inhibidores de girasa y topoisomerasa
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases
US9018216B2 (en) 2012-07-18 2015-04-28 Vertex Pharmaceuticals Incorporated Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof
SG11201606332PA (en) 2014-02-03 2016-09-29 Spero Gyrase Inc Antibacterial combinations comprising polymyxin
CN104230991A (zh) * 2014-08-25 2014-12-24 亿腾药业(泰州)有限公司 一种控制福沙吡坦二甲葡胺中钯残留的方法
WO2016119700A1 (en) * 2015-01-28 2016-08-04 Jn Therapeutics Substituted imidazo [1, 2-a] pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
CN106167486B (zh) * 2015-05-22 2019-06-14 北京四环制药有限公司 单环类回旋酶和拓扑异构酶iv抑制剂
TWI828027B (zh) 2016-03-28 2024-01-01 美商英塞特公司 作為tam抑制劑之吡咯并三嗪化合物
JP6888101B2 (ja) * 2017-01-18 2021-06-16 アレイ バイオファーマ インコーポレイテッド RETキナーゼ阻害剤としての置換ピラゾロ[1,5−a]ピラジン化合物
RU2019133662A (ru) 2017-03-24 2021-04-26 Тайсо Фармасьютикал Ко., Лтд. Производное 2(1h)-хинолинона
WO2019057946A1 (en) 2017-09-25 2019-03-28 F. Hoffmann-La Roche Ag MULTI-CYCLIC AROMATIC COMPOUNDS AS D-FACTOR INHIBITORS
WO2019126731A1 (en) 2017-12-22 2019-06-27 Petra Pharma Corporation Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
TW202112767A (zh) 2019-06-17 2021-04-01 美商佩特拉製藥公司 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
BR112022002815A2 (pt) * 2019-08-15 2022-05-10 Bayer Ag Método para preparar 2-(fenilimino)-3-alquil-1,3-tiazolidin- 4-onas
CN115315425B (zh) * 2020-08-14 2025-03-28 上海复旦张江生物医药股份有限公司 一种取代的咪唑并[1,2-a]吡啶-2-基酰胺化合物的制备方法及其中间体
CN115073358B (zh) * 2022-07-21 2023-09-26 安徽德诺医药股份有限公司 一种n-苄基-4-哌啶甲酸乙酯的制备方法
CN118955404B (zh) * 2024-07-30 2026-06-12 凯美克(上海)医药科技有限公司 一种化合物3,5-二溴哒嗪的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
PL362691A1 (en) * 2000-12-15 2004-11-02 Vertex Pharmaceuticals Incorporated Bacterial gyrase inhibitors and uses thereof
US8404852B2 (en) * 2003-01-31 2013-03-26 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7569591B2 (en) * 2003-01-31 2009-08-04 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7618974B2 (en) * 2003-01-31 2009-11-17 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US20090281097A1 (en) * 2006-04-14 2009-11-12 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
EP2321309A1 (en) * 2008-06-25 2011-05-18 Ranbaxy Laboratories Limited Benzothiazoles and aza-analogues thereof use as antibacterial agents
WO2010100144A1 (en) * 2009-03-04 2010-09-10 Merck Serono S.A. Fused bicyclic compounds as inhibitors for pi3 kinase

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015514063A (ja) * 2012-03-22 2015-05-18 ビオタ ヨーロッパ リミテッドBiota Europe Ltd 抗菌化合物

Also Published As

Publication number Publication date
CN103249732B (zh) 2016-08-10
US9181234B2 (en) 2015-11-10
EP2625178A4 (en) 2014-04-30
AU2011313820A1 (en) 2013-04-11
WO2012045124A1 (en) 2012-04-12
US20120088750A1 (en) 2012-04-12
CN103249732A (zh) 2013-08-14
JP2013542204A (ja) 2013-11-21
EP2625178A1 (en) 2013-08-14

Similar Documents

Publication Publication Date Title
JP2013542204A (ja) 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類
EP3630770B1 (en) Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
AU2015323572B2 (en) Novel compounds
AU2022349569A1 (en) Pyridine derivative and use thereof
KR101443795B1 (ko) 항균성 조성물
DE602004009089T2 (de) Pyrrolderivate mit antibakterieller wirkung
KR102007056B1 (ko) 과증식성 질환 치료시 Bub1 키나제 저해제로 사용하기 위한 치환된 벤질인다졸
JP5561702B2 (ja) Pi3キナーゼ調節剤および使用方法
US11420966B2 (en) Substituted pyrrolopyridines as JAK inhibitors
ES2784655T3 (es) 1H-pirazolo[4,3-b]piridinas como inhibidores de PDE1
US20120101100A1 (en) Heterocyclic urea derivatives and methods of use thereof-211
JP2021514359A (ja) キナーゼ阻害剤としての複素環式化合物
KR20170040300A (ko) 2-(모르폴린-4-일)-l,7-나프티리딘
TW201111380A (en) Heterocyclic urea derivatives and methods of use thereof
KR20140117651A (ko) 이소퀴놀린 및 나프티리딘 유도체
KR20230112605A (ko) 키나아제 억제제 및 그의 용도
ES2899868T3 (es) Tratamientos de combinación que comprenden la administración de 1H-pirazolo[4,3-b]piridinas
WO2020083856A1 (en) 5-azaindazole derivatives as adenosine receptor antagonists
AU2015212495A1 (en) Antibacterial combinations comprising polymyxin
US12565494B2 (en) Inhibitors of human respiratory syncytial virus and metapneumovirus
US20260138956A1 (en) Novel compounds and uses thereof
AU2012203026B2 (en) Novel heterocyclic compounds and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141003

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141003

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150519

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20150521

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150817

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151013

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151029

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151208

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151224

R150 Certificate of patent or registration of utility model

Ref document number: 5864589

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees